OTHER INCOME (LOSS)

6 Months Ended

Jun. 30, 2023

Other Income and Expenses [Abstract]

OTHER INCOME (LOSS)

NOTE 19. OTHER INCOME (LOSS)

	Three months ended June 30				Six months ended June 30
	2023		2022		2023		2022
Investment in GE HealthCare realized and unrealized gain (loss)	$	(214)	$	—	$	5,879	$	—
Investment in and note with AerCap realized and unrealized gain (loss)	572		(1,071)		378		(2,807)
Investment in Baker Hughes realized and unrealized gain (loss)	—		(459)		10		1,056
Gains (losses) on retained and sold ownership interests	$	358	$	(1,530)	$	6,266	$	(1,751)
Other net interest and investment income (loss)	155		54		341		147
Licensing and royalty income	91		29		125		86
Equity method income	68		77		69		115
Other items	20		142		(28)		224
Total other income (loss)	$	692	$	(1,227)	$	6,773	$	(1,178)

    

Our investment in GE HealthCare comprises 61.6 million shares (approximately 13.5% ownership interest) at June 30, 2023. During the six months ended June 30, 2023, we received total proceeds of $2,192 million from the disposition of GE HealthCare shares. Our investment in AerCap comprises 78.2 million ordinary shares (approximately 33.6% ownership interest) at June 30, 2023 and an AerCap senior note. During the six months ended June 30, 2023, we received total proceeds of $1,898 million from the sale of AerCap shares. During the first quarter of 2023, we received proceeds of $216 million from the sale of Baker Hughes shares and have now fully monetized our position.